Early High-dosage Atorvastatin Treatment Improved Serum Immune-inflammatory Markers and Functional Outcome in Acute Ischemic Strokes Classified as Large Artery Atherosclerotic Stroke

MLA

Tuttolomondo, Antonino, et al. “Early High-Dosage Atorvastatin Treatment Improved Serum Immune-Inflammatory Markers and Functional Outcome in Acute Ischemic Strokes Classified as Large Artery Atherosclerotic Stroke.” Medicine, vol. 95, no. 13, Mar. 2016, p. e3186. EBSCOhost, https://doi.org/10.1097/MD.0000000000003186.

APA

Tuttolomondo, A., Di Raimondo, D., Pecoraro, R., Maida, C., Arnao, V., Corte, V. D., Simonetta, I., Corpora, F., Di Bona, D., Maugeri, R., Iacopino, D. G., Pinto, A., & Ford., I. (2016). Early High-dosage Atorvastatin Treatment Improved Serum Immune-inflammatory Markers and Functional Outcome in Acute Ischemic Strokes Classified as Large Artery Atherosclerotic Stroke. Medicine, 95(13), e3186. https://doi.org/10.1097/MD.0000000000003186

Chicago

Tuttolomondo, Antonino, Domenico Di Raimondo, Rosaria Pecoraro, Carlo Maida, Valentina Arnao, Vittoriano Della Corte, Irene Simonetta, et al. 2016. “Early High-Dosage Atorvastatin Treatment Improved Serum Immune-Inflammatory Markers and Functional Outcome in Acute Ischemic Strokes Classified as Large Artery Atherosclerotic Stroke.” Medicine 95 (13): e3186. doi:10.1097/MD.0000000000003186.